tag game-based-therapies 
XTalks
DECEMBER 13, 2023
The US Food and Drug Administration (FDA) has approved the first gene therapies for the treatment of sickle cell disease, approving two on the same day. Both gene therapies are approved for individuals 12 years of age and older with sickle cell disease. Casgevy is also the first ever CRISPR/Cas9-based therapy approved in the US.
pharmaphorum
JUNE 15, 2021
The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. So we know change is not impossible.
Drug Discovery World
NOVEMBER 9, 2023
Kielczewska will present: ‘Discovery of antibody-based therapeutics to challenging targets: Platform considerations’. Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’.
Expert insights. Personalized for you.
98 
Let's personalize your content